These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6820892)

  • 1. [Clinical study of preoperative chemotherapy of primary breast cancer. 1. Efficacy of a combined use of CPA (endoxan) and FT-207 (or 5-FU dry syrup)].
    Komuro K; Hara Y; Fujii Y; Yamazaki M; Amano R; Hashiguchi F; Sakamoto R; Nakamura R; Shimada A; Kurata T; Ando H; Nakamura K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2180-5. PubMed ID: 6820892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on preoperative chemotherapy of primary breast cancer. 2--A comparative study of CPA + FT-207 (5-FUDS) and CPA + FT-207 (5-FUDS) + MMC].
    Komuro K; Hara Y; Fujii Y; Nagayama A; Kobayashi T; Gotoh M; Hagiwara H; Nakamura R; Nagasaki Y; Kataoka J; Andoh H; Nakamura K
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1454-60. PubMed ID: 6307168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of pre-operative chemotherapy using FT-207 suppositories combined with glutathione--with special reference to histopathological antitumor effect].
    Kaga F; Kitajima M; Ikeda Y; Seki M; Yagita A; Sohma S; Fukuzumi N
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):489-95. PubMed ID: 6820899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A double-blind randomized comparative study of oral 5-fluorouracil (5-FU), cyclophosphamide (CPA), and 5-FU + CPA in advanced breast cancer].
    Takayama T; Nomura Y
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):73-80. PubMed ID: 10660736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The feasibility of CEF (cyclophosphamide, epirubicin, 5-FU) regimen in the adjuvant setting of primary breast cancer].
    Honda S; Toi M; Shimizu S; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):679-83. PubMed ID: 9126304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].
    Suemasu K; Nomoto C; Higashi Y
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):667-71. PubMed ID: 6820904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
    Yamaguchi S; Fukuda M; Ota T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1145-52. PubMed ID: 10431580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
    Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
    Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical investigation of the combination therapy of 1-(2-tetrahydrofuryl)-5-fluorouracil (FH) fine granules and 5-FU dry syrup].
    Nakazawa I; Goto Y; Ouchi E; Nomura N; Suzuki N; Kikuchi T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):722-5. PubMed ID: 6820906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral UFT and cyclophosphamide combination chemotherapy for metastatic breast cancer.
    Ogawa Y; Ishikawa T; Chung SH; Ikeda K; Takashima T; Onoda N; Nakata B; Nishiguchi Y; Hirakawa K
    Anticancer Res; 2003; 23(4):3453-7. PubMed ID: 12926089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
    Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
    Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
    Ogawa Y; Ishikawa T; Ogisawa K; Ikeda K; Nagatsuka I; Matsumura Y; Takashima T; Yashiro M; Onoda N; Nakata B; Kato Y; Hirakawa K
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2123-7. PubMed ID: 11103246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pre- and intra-operative chemotherapy using FT-207 suppositories--with special reference to lung cancer].
    Fukuda K; Komatubara S; Sato G; Teramoto S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2212-5. PubMed ID: 6307181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
    Grossie VB; Rosenblum MG; Loo TL
    Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
    Kiman K; Suzuki S; Satomi T; Sakonji M; Nihei M; Tanaka T; Kimijima I; Abe R
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2445-52. PubMed ID: 7944490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.